SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001613377-18-000039
Filing Date
2018-11-29
Accepted
2018-11-29 12:16:08
Documents
1
Period of Report
2018-11-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3212
  Complete submission text file 0001613377-18-000039.txt   4533
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 215-988-0080
HEMISPHERX BIOPHARMA INC (Issuer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2117 SW HIGHWAY 484 OCALA FL 34473
Business Address
MITCHELL WILLIAM M (Reporting) CIK: 0001191434 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-27072 | Film No.: 181207563